Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cobimetinib + Vemurafenib in BRAFV600-mutated Melanoma with Brain Metastasis
NCT02537600Phase 2Completed
- Sponsor
- Centre Eugène Marquis
- Start
- Dec 2015
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cobimetinib in cutaneous melanoma (CM), sponsored by Centre Eugène Marquis. Started Dec 2015; status: completed.
02
Drugs
cobimetinib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT02537600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537600.